𝔖 Bobbio Scriptorium

✦ LIBER ✦

Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients

✍ Scribed by Tomoichiro Asano; Yasushi Saito; Masanobu Kawakami; Nobuhiro Yamada

Book ID: 114343499
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 112 KB
Volume: 16
Category: Article
ISSN: 1056-8727
DOI: 10.1016/s1056-8727(01)00175-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erythrocytic sorbitol contents in diabet

Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860)

✍ Tomoichiro Asano; Yasushi Saito; Masanobu Kawakami; Nobuhiro Yamada; Hisakuni Se 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Effects of a new aldose reductase inhibi

Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats

✍ Kuniharu Mizuno; Noriaki Kato; Akira Matsubara; Kazumasa Nakano; Masayasu Kurono 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 805 KB